CD46 and myasthenia gravis: A recent study used a triple knockout cell line (CD46, CD55, and CD59 deficient) to study complement activation in patients with myasthenia gravis.36 We observed higher CD59 levels in the transfected cells compared with nontransfected cells; however, levels were comparable between MOG and AQP4 transfections.